Best of ESGO 2017

BRING THE
BEST OF ESGO 2017
TO YOUR LOCAL EVENT

 

The Best of ESGO is a slide deck
+ Focused on 15 Selected Oral Presentations from ESGO 2017
+ Designed to briefly summarise the key findings of the selected
studies in gynaecological Cancers
+ Available only in English

 

 

 

Overview

The Best of ESGO 2017 project highlights the most relevant data presented at the world’s biggest gynecologic oncology event in 2017: the 20th international meeting of the European Society of Gynaecological Oncology.

The abstracts chosen for this presentation and discussion reflect the foremost clinical research and strategies in oncology that will impact our patient care.

The slides report the most recent relevant findings in the treatment of gynecological malignancies presented at the Vienna congress in November 2017.

 

Among the Top 15 Selected Studies:

• REFINEMENT OF HIGH-RISK ENDOMETRIAL-CANCER (HR-EC) CLASSIFICATION USING DNA DAMAGE RESPONSE (DDR) BIOMARKERS: A TRANSPORTEC INITIATIVE
• QUALITY OF LIFE WITH WEEKLY, DOSE-DENSE VERSUS STANDARD CHEMOTHERAPY FOR OVARIAN CANCER IN THE ICON8 STUDY
• ARIEL3: PHASE 3, RANDOMISED, DOUBLE-BLINED STUDY OF RUCAPARIB vs PLACEBO FOLLOWING RESPONSE TO PLATINUM-BASED CHEMOTHERAPY FOR RECURRENT OVARIAN CARCINOMA
• LION – LYMPHADENECTOMY IN OVARIAN NEOPLASMS. A PROSPECTIVE RANDOMIZED AGO STUDY GROUP LED GYNECOLOGIC CANCER INTERGROUP TRIAL

 

Interested to find out more ?

Contact us: adminoffice@esgo.org